Table 3.
Comparison across activity variables of associations and model fit in cross-sectional and longitudinal models
| MVPA + ST | Average cpm | |||||||
|---|---|---|---|---|---|---|---|---|
| MVPA* % difference | P value | ST† % difference | P value | R2 | Cpm* % difference | P value | R2 | |
| Cross-sectional (n = 2,027) | ||||||||
| Fasting glucose (mg/dL)‡ | ||||||||
| Model 2 | −2.2 | <0.001 | 0.6 | 0.228 | 7.6% | −2.3 | <0.001 | 7.7% |
| Model 3 | −1.3 | <0.001 | −0.2 | 0.561 | 45.6% | −0.9 | <0.001 | 45.5% |
| 2-h glucose (mg/dL)‡§ | ||||||||
| Model 2 | −4.1 | <0.001 | 0.6 | 0.542 | 7.4% | −4.0 | <0.001 | 7.4% |
| Model 3 | −3.2 | <0.001 | −0.1 | 0.932 | 29.2% | −2.8 | <0.001 | 29.1% |
| Fasting insulin (mU/L)‡ | ||||||||
| Model 2 | −7.5 | <0.001 | 4.4 | 0.005 | 10.2% | −9.5 | <0.001 | 10.5% |
| Model 3 | −3.9 | 0.001 | 3.5 | 0.007 | 36.2% | −5.6 | <0.001 | 36.3% |
| HOMA-IR‡ | ||||||||
| Model 2 | −9.5 | <0.001 | 5.0 | 0.006 | 11.4% | −11.6 | <0.001 | 11.7% |
| Model 3 | −5.1 | <0.001 | 3.3 | 0.021 | 43.5% | −6.5 | <0.001 | 43.5% |
| HbA1c (%)‡‖ | ||||||||
| Model 2 | −0.8 | 0.028 | 0.2 | 0.646 | 9.2% | −0.9 | 0.002 | 9.4% |
| Model 3 | −0.2 | 0.525 | −0.2 | 0.176 | 49.0% | 0.1 | 0.616 | 49.0% |
| MVPA + ST | Average cpm | |||||||
|---|---|---|---|---|---|---|---|---|
| Std β MVPA* | P value | Std β ST† | P value | R2 | Std β cpm* | P value | R2 | |
| 5-year change (n = 1,718) | ||||||||
| Fasting glucose (mg/dL) | ||||||||
| Model 2 | 0.49 | 0.173 | 0.38 | 0.192 | 7.9% | 0.07 | 0.803 | 7.9% |
| Model 3 | 0.71 | 0.019 | 0.25 | 0.446 | 34.9% | 0.32 | 0.201 | 34.8% |
| 2-h glucose (mg/dL)¶ | ||||||||
| Model 2 | −2.66 | 0.005 | −1.06 | 0.708 | 17.7% | −1.46 | 0.070 | 17.5% |
| Model 3 | −1.58 | 0.068 | −0.67 | 0.548 | 33.5% | −0.83 | 0.256 | 33.4% |
| Fasting insulin (mU/L) | ||||||||
| Model 2 | −0.10 | 0.608 | 0.21 | 0.164 | 15.4% | −0.19 | 0.250 | 15.4% |
| Model 3 | −0.12 | 0.470 | 0.07 | 0.708 | 23.1% | −0.13 | 0.363 | 23.2% |
| HOMA-IR | ||||||||
| Model 2 | 0.01 | 0.889 | 0.08 | 0.128 | 11.8% | −0.04 | 0.427 | 11.8% |
| Model 3 | 0.01 | 0.853 | 0.04 | 0.399 | 27.0% | −0.02 | 0.632 | 27.1% |
| HbA1c (%)# | ||||||||
| Model 2 | 0.01 | 0.351 | 0.02 | 0.063 | 2.7% | −0.01 | 0.390 | 2.5% |
| Model 3 | 0.02 | 0.047 | 0.02 | 0.058 | 37.0% | 0.00 | 0.912 | 36.8% |
Model 2 adjusted for demographics, lifestyle, accelerometers wear time, and log-transformed MVPA (total minutes); model 3 adjusted for the same as model 2 + BMI, hypertension, diabetes, and total cholesterol (+5-year change in longitudinal model). Boldface type denotes statistically significant associations. Std, standardized.
*MVPA and cpm were log transformed. The standardized β coefficients presented are based on the SD of the independent variable and represent the difference that would be expected with an approximate doubling of MVPA (e.g., 60 vs. 120 min) and an ∼50% increase in cpm (e.g., 400 vs. 600 cpm);
†the standardized β coefficients are based on the SD of ST in this sample and represent the difference that would be expected with a 1-h and 45-min difference in ST;
‡dependent variables were log transformed in cross-sectional models; thus, the β presented is the percent difference associated with each additional standardized increase in MVPA, ST, or average cpm;
§missing in 400 participants;
‖missing in 261 participants;
¶missing in 401 participants;
#missing for 244 participants.